Please assess the completion status of the following clinical trial:

Trial Title: Noradrenalin vs Terlipressin in Hepatorenal Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Hepatorenal syndrome~* Age: 18-75 years~* Informed written consent~Exclusion Criteria:~* Multinodular hepatocellular carcinoma (more than 3 nodules)~* Portal vein thrombosis~* Ongoing bacterial infection~* Ongoing or recent (less than one week) bleeding~* Cardio-pulmonary failure~* Coronary artery disease~* Peripheral artery disease~* Arterial hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 2 (Type: ACTIVE_COMPARATOR): Terlipressin
- 1 (Type: EXPERIMENTAL): Noradrenalin

Based on this trial design, predict the completion outcome and termination type (if applicable).